Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $64.59 million. The enterprise value is $64.24 million.
Important Dates
The last earnings date was Tuesday, November 10, 2026, after market close.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 10.19 million shares outstanding. The number of shares has increased by 21.84% in one year.
| Current Share Class | 10.19M |
| Shares Outstanding | 10.19M |
| Shares Change (YoY) | +21.84% |
| Shares Change (QoQ) | +1.95% |
| Owned by Insiders (%) | 3.62% |
| Owned by Institutions (%) | 20.79% |
| Float | 4.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.36 |
| PS Ratio | 16.21 |
| Forward PS | 1.85 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72
| Current Ratio | 1.72 |
| Quick Ratio | 1.62 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -0.03% |
| Return on Invested Capital (ROIC) | -0.10% |
| Return on Capital Employed (ROCE) | -88.12% |
| Weighted Average Cost of Capital (WACC) | 6.71% |
| Revenue Per Employee | $396,500 |
| Profits Per Employee | -$1.46M |
| Employee Count | 10 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATRA has paid $1,000 in taxes.
| Income Tax | 1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.90% in the last 52 weeks. The beta is 0.32, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -52.90% |
| 50-Day Moving Average | 8.67 |
| 200-Day Moving Average | 7.86 |
| Relative Strength Index (RSI) | 30.52 |
| Average Volume (20 Days) | 24,391 |
Short Selling Information
The latest short interest is 296,651, so 2.91% of the outstanding shares have been sold short.
| Short Interest | 296,651 |
| Short Previous Month | 350,260 |
| Short % of Shares Out | 2.91% |
| Short % of Float | 6.20% |
| Short Ratio (days to cover) | 9.41 |
Income Statement
In the last 12 months, ATRA had revenue of $3.97 million and -$14.61 million in losses. Loss per share was -$1.01.
| Revenue | 3.97M |
| Gross Profit | 4.09M |
| Operating Income | -10.61M |
| Pretax Income | -14.61M |
| Net Income | -14.61M |
| EBITDA | -10.51M |
| EBIT | -10.61M |
| Loss Per Share | -$1.01 |
Full Income Statement Balance Sheet
The company has $9.92 million in cash and $9.57 million in debt, with a net cash position of $351,000 or $0.03 per share.
| Cash & Cash Equivalents | 9.92M |
| Total Debt | 9.57M |
| Net Cash | 351,000 |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | -37.90M |
| Book Value Per Share | -3.72 |
| Working Capital | 4.75M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -21.90M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 851,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -21.90M |
| FCF Per Share | -$2.15 |
Full Cash Flow Statement Margins
| Gross Margin | 103.25% |
| Operating Margin | -267.57% |
| Pretax Margin | -368.55% |
| Profit Margin | n/a |
| EBITDA Margin | -265.17% |
| EBIT Margin | -267.57% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.84% |
| Shareholder Yield | -21.84% |
| Earnings Yield | -15.94% |
| FCF Yield | -34.06% |
Analyst Forecast
The average price target for ATRA is $13.67, which is 115.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.67 |
| Price Target Difference | 115.62% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -42.54% |
| EPS Growth Forecast (3Y) | -20.53% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ATRA has an Altman Z-Score of -153.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -153.51 |
| Piotroski F-Score | 2 |